The human papillomavirus HPV test detects the presence of human papillomavirus, a virus that can lead to the development of genital warts, abnormal cervical cells or cervical cancer. The HPV testing is further classified into three subsegments, namely, followup testing, cotesting, HPV primary testing.
HPV Testing is mainly used in Cervical Cancer Screening. Cervical Cancer Screening is the biggest application. The main suppliers of HPV testing in the market include Qiagen, Roche Diagnostics, Hologic, Abbott Laboratories, BD and Seegene, Inc., Qiagen is the biggest supplier, in 2016 Qiagen revenue was about $ 194.13 million and in 2017 Qiagen revenue will be about $ 204.06 million.Global HPV testing market can be divided into two big markets: Europe and North America. North America is the largest HPV testing region, in 2016, North America HPV testing revenue was about $ 248.12 million in 2016, in 2017, USA HPV testing revenue will be about $ 270.49 million.
Over the next five years, LPILP Information projects that HPV Testing will register a 8.4% CAGR in terms of revenue, reach US$ 930 million by 2023, from US$ 580 million in 2017.
This report studies the global market, especially in North America, Europe, AsiaPacific, South America, Middle East and Africa, focuses on the top 5 players in each region, with sales, price, revenue and market share from 2013 to 2018, the top players:
Qiagen
Roche Diagnostics
Hologic
Abbott Laboratories
BD
Seegene, Inc.
Market Segment by Regions, this report splits Global into several key Regions, with sales, revenue, market share of top players in these regions, from 2013 to 2018 forecast, like
North America United States, Canada and Mexico
AsiaPacific China, Japan, Southeast Asia, India and Korea
Europe Germany, UK, France, Italy and Russia etc.
South America Brazil, Chile, Peru and Argentina
Middle East and Africa Egypt, South Africa, Saudi Arabia
Split by Product Types, with sales, revenue, price, market share of each type, can be divided into
HPV Testing
Followup HPV Testing
Cotesting
Split by applications, this report focuses on sales, market share and growth rate in each application, can be divided into
Cervical Cancer Screening
Vaginal Cancer Screening
Other